$RPTX
Repare Therapeutics Inc.

2020 Q3 Form 10-Q Financial Statement

#000156459020053203 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.200M $1.300M $1.030M
YoY Change 223.08%
% of Gross Profit
Research & Development $10.09M $5.600M $4.853M
YoY Change 80.2%
% of Gross Profit
Depreciation & Amortization $210.0K $160.0K $140.0K
YoY Change 31.25%
% of Gross Profit
Operating Expenses $14.09M $6.900M $5.885M
YoY Change 104.16%
Operating Profit -$14.09M -$5.885M
YoY Change
Interest Expense $450.0K -$800.0K -$450.0K
YoY Change -156.25%
% of Operating Profit
Other Income/Expense, Net $442.0K -$791.0K -$454.0K
YoY Change -155.88%
Pretax Income -$13.65M -$7.659M -$6.339M
YoY Change 78.16%
Income Tax $106.0K $29.00K $20.00K
% Of Pretax Income
Net Earnings -$13.75M -$7.700M -$6.360M
YoY Change 78.57%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$374.0K -$0.22 -$181.6K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $347.9M
YoY Change
Cash & Equivalents $348.1M $104.9M $28.79M
Short-Term Investments
Other Short-Term Assets $8.500M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $361.3M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $8.300M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $700.0K
YoY Change
Total Long-Term Assets $8.900M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $361.3M
Total Long-Term Assets $8.900M
Total Assets $370.2M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.800M
YoY Change
Accrued Expenses $5.600M
YoY Change
Deferred Revenue $2.150M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.20M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $59.30M
YoY Change
Total Long-Term Liabilities $59.30M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.20M
Total Long-Term Liabilities $59.30M
Total Liabilities $69.40M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $300.8M -$38.00M -$33.40M
YoY Change
Total Liabilities & Shareholders Equity $370.2M
YoY Change

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$13.75M -$7.700M -$6.360M
YoY Change 78.57%
Depreciation, Depletion And Amortization $210.0K $160.0K $140.0K
YoY Change 31.25%
Cash From Operating Activities -$20.11M -$5.850M -$6.080M
YoY Change 243.76%
INVESTING ACTIVITIES
Capital Expenditures -$480.0K $180.0K -$300.0K
YoY Change -366.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$480.0K -$180.0K -$300.0K
YoY Change 166.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.700M 82.24M 0.000
YoY Change -102.07%
NET CHANGE
Cash From Operating Activities -20.11M -5.850M -6.080M
Cash From Investing Activities -480.0K -180.0K -300.0K
Cash From Financing Activities -1.700M 82.24M 0.000
Net Change In Cash -22.29M 76.21M -6.380M
YoY Change -129.25%
FREE CASH FLOW
Cash From Operating Activities -$20.11M -$5.850M -$6.080M
Capital Expenditures -$480.0K $180.0K -$300.0K
Free Cash Flow -$19.63M -$6.030M -$5.780M
YoY Change 225.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2150000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
218000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4246000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
439000
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
55992000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8142000
CY2019Q4 us-gaap Liabilities
Liabilities
12827000
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
135997000
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2019 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1528374
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1528374
CY2019Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
rptx Preferred Stock Authorized Unlimited
PreferredStockAuthorizedUnlimited
Unlimited
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14174000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3358000
us-gaap Operating Expenses
OperatingExpenses
17532000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
271000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
147000
rptx Change In Fair Value Of Preferred Share Tranche Obligation
ChangeInFairValueOfPreferredShareTrancheObligation
1337000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
156000
us-gaap Investment Income Interest
InvestmentIncomeInterest
156000
CY2019Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
10000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-791000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-700000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1195000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7659000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37925000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18727000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
229000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000
CY2019Q3 rptx Net Income Loss And Comprehensive Income Loss
NetIncomeLossAndComprehensiveIncomeLoss
-7688000
rptx Net Income Loss And Comprehensive Income Loss
NetIncomeLossAndComprehensiveIncomeLoss
-38154000
rptx Net Income Loss And Comprehensive Income Loss
NetIncomeLossAndComprehensiveIncomeLoss
-18885000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7688000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38154000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18885000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.63
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-12.36
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1528374
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14486896
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1528374
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-22384000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
65000
CY2019Q1 rptx Net Income Loss And Comprehensive Income Loss
NetIncomeLossAndComprehensiveIncomeLoss
-4838000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-27157000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
121000
CY2019Q2 rptx Net Income Loss And Comprehensive Income Loss
NetIncomeLossAndComprehensiveIncomeLoss
-6359000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-33395000
CY2019Q3 rptx Temporary Equity Adjustments To Additional Paid In Capital Termination
TemporaryEquityAdjustmentsToAdditionalPaidInCapitalTermination
2960000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-37996000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
324000
CY2020Q1 rptx Net Income Loss And Comprehensive Income Loss
NetIncomeLossAndComprehensiveIncomeLoss
-12601000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-58135000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
164000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
389000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
135997000
CY2020Q2 rptx Issuance Of Warrants And Conversion Into Common Stock During Period Value
IssuanceOfWarrantsAndConversionIntoCommonStockDuringPeriodValue
15000000
CY2020Q2 rptx Net Income Loss And Comprehensive Income Loss
NetIncomeLossAndComprehensiveIncomeLoss
-11802000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-516000
CY2019Q3 us-gaap Cash
Cash
104731000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
313656000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
22000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
871000
us-gaap Profit Loss
ProfitLoss
-38154000
us-gaap Profit Loss
ProfitLoss
-18885000
us-gaap Share Based Compensation
ShareBasedCompensation
1531000
us-gaap Share Based Compensation
ShareBasedCompensation
313000
us-gaap Depreciation
Depreciation
610000
us-gaap Depreciation
Depreciation
416000
rptx Change In Fair Value Of Preferred Stock Tranche Obligation
ChangeInFairValueOfPreferredStockTrancheObligation
1350000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
520000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
191000
rptx Foreign Currency Transaction Gain Loss
ForeignCurrencyTransactionGainLoss
-835000
rptx Foreign Currency Transaction Gain Loss
ForeignCurrencyTransactionGainLoss
432000
rptx Investment Income Interest Net
InvestmentIncomeInterestNet
36000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8834000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
142000
rptx Increase Decrease In Research And Development Tax Credits Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditsReceivable
584000
rptx Increase Decrease In Research And Development Tax Credits Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditsReceivable
398000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1247000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
964000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
86000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
83000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-71000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1120000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1157000
rptx Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
3540000
rptx Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
318000
rptx Increase Decrease In Operating Lease Liability Current
IncreaseDecreaseInOperatingLeaseLiabilityCurrent
-97000
rptx Increase Decrease In Operating Lease Liability Current
IncreaseDecreaseInOperatingLeaseLiabilityCurrent
29000
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
265000
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
132000
rptx Increase Decrease In Operating Lease Liability Net
IncreaseDecreaseInOperatingLeaseLiabilityNet
-351000
rptx Increase Decrease In Operating Lease Liability Net
IncreaseDecreaseInOperatingLeaseLiabilityNet
-223000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
50000000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8142000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6863000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9083000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
516000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
561000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-561000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
510000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
15000000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
232043000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
247553000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103243000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-830000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
407000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
253070000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
94006000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
95005000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10929000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
348075000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
104935000
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
203000
CY2019Q3 us-gaap Restricted Cash
RestrictedCash
204000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
348075000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104935000
us-gaap Interest Paid Net
InterestPaidNet
120000
rptx Property And Equipment Purchases In Accounts Payable And Accrued Expenses And Other Current Liabilities
PropertyAndEquipmentPurchasesInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
950000
rptx Property And Equipment Purchases In Accounts Payable And Accrued Expenses And Other Current Liabilities
PropertyAndEquipmentPurchasesInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
542000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4516000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1074000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
135997000
rptx Issuance Of Warrants And Conversion Into Common Stock During Period Value
IssuanceOfWarrantsAndConversionIntoCommonStockDuringPeriodValue
15000000
CY2020Q3 us-gaap Lease Cost
LeaseCost
299000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in consolidated financial statements and accompanying notes. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, estimates related to revenue recognition, accrued research and development expenses, share-based compensation, right-of-use assets and lease liabilities and income taxes. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. The Company bases its estimates on historical experience and other market specific or other relevant assumptions that it believes to be reasonable under the circumstances. Actual results could materially differ from those estimates. Changes in estimates are recorded in the period in which they become known.</p>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2016-09-06
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-6.062
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.16496
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1795000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1043000
CY2020Q3 rptx Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
2735000
CY2019Q4 rptx Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
208000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
286000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
21000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
107000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4000
CY2020Q3 rptx Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
4923000
CY2019Q4 rptx Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
1276000
rptx Number Of Operating Leases
NumberOfOperatingLeases
4
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
false
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
249000
us-gaap Operating Lease Cost
OperatingLeaseCost
579000
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
34000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
38000
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
16000
us-gaap Variable Lease Cost
VariableLeaseCost
108000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y6M
rptx Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-18885000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0043
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0043
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0223
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y25D
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
11401000
us-gaap Lease Cost
LeaseCost
725000
us-gaap Operating Lease Payments
OperatingLeasePayments
513000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y4M13D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3505119
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
907315
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
899274
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1080442
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
278246
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
34637
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5485
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4091510
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1982272
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.07
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.66
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.61
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.83
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.96
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.06
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.28
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.87
rptx Additional Paid In Capital Share Based Payment Arrangement Exercised Options Credited To Common Shares
AdditionalPaidInCapitalShareBasedPaymentArrangementExercisedOptionsCreditedToCommonShares
301000
CY2020Q3 rptx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Stock Options
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfStockOptions
14.42
CY2019Q3 rptx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Stock Options
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfStockOptions
1.22
rptx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Stock Options
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfStockOptions
10.43
rptx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Stock Options
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfStockOptions
0.99
CY2020Q3 rptx Share Based Compensation Arrangement By Share Based Payment Award Exercise Price Through Fair Value Assumptions
ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceThroughFairValueAssumptions
24.00
CY2019Q3 rptx Share Based Compensation Arrangement By Share Based Payment Award Exercise Price Through Fair Value Assumptions
ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceThroughFairValueAssumptions
1.89
rptx Share Based Compensation Arrangement By Share Based Payment Award Exercise Price Through Fair Value Assumptions
ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceThroughFairValueAssumptions
16.61
rptx Share Based Compensation Arrangement By Share Based Payment Award Exercise Price Through Fair Value Assumptions
ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceThroughFairValueAssumptions
2.05
CY2020Q3 rptx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
23.28
CY2019Q3 rptx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
1.88
rptx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
16.58
rptx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
2.05
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y25D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7130
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7120
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7199
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7082
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020Q3 rptx Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-13751000
CY2019Q3 rptx Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-7688000
rptx Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-38154000

Files In Submission

Name View Source Status
0001564590-20-053203-index-headers.html Edgar Link pending
0001564590-20-053203-index.html Edgar Link pending
0001564590-20-053203.txt Edgar Link pending
0001564590-20-053203-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gr4iwuu33csp000001.jpg Edgar Link pending
gr4iwuu33csp000002.jpg Edgar Link pending
gr4iwuu33csp000003.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rptx-10q_20200930.htm Edgar Link pending
rptx-20200930.xml Edgar Link completed
rptx-20200930.xsd Edgar Link pending
rptx-20200930_cal.xml Edgar Link unprocessable
rptx-20200930_def.xml Edgar Link unprocessable
rptx-20200930_lab.xml Edgar Link unprocessable
rptx-20200930_pre.xml Edgar Link unprocessable
rptx-ex101_111.htm Edgar Link pending
rptx-ex102_209.htm Edgar Link pending
rptx-ex311_9.htm Edgar Link pending
rptx-ex312_6.htm Edgar Link pending
rptx-ex321_10.htm Edgar Link pending
rptx-ex322_7.htm Edgar Link pending
Show.js Edgar Link pending